Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Introduction
After a long eclipse, in recent years different lines of work have lead to a renaissance of the inflammation–cancer connection [1, 2, 3]. Selected forms of chronic inflammation predispose to cancer, including microbial infections (e.g. Helicobacter pilori for gastric cancer and mucosal lymphoma), autoimmune diseases (e.g. colitis-associated cancer), and inflammatory conditions of uncertain origin (e.g. prostate cancer). Usage of non-steroidal anti-inflammatory agents protects against various tumors. Moreover, smouldering inflammation is a key characteristic of the microenvironment of most neoplastic tissues, including those not etiologically related to inflammatory processes. Inflammation has been suggested to represent the 7th hallmark of cancer [4•].
Recent efforts have shed new light on molecular and cellular pathways linking inflammation and cancer [2]. Two pathways link inflammation and cancer. In the intrinsic pathway, activation of different classes of oncogenes drives the expression of inflammation-related programs that guide the construction of an inflammatory microenvironment. In the extrinsic pathway, inflammatory conditions promote cancer development (e.g. colitis-associated cancer of the intestine). Key orchestrators at the intersection of the intrinsic and extrinsic pathway include transcription factors (e.g. NF-κB; Stat3; HIF) [5, 6•, 7], cytokines (e.g. TNF), and chemokines. Thus, inflammation is a key component of the tumor microenvironment and a target for pharmacologic intervention.
Tumor-associated macrophages (TAM) are a major component of leukocytic infiltrate of tumors and have served as a paradigm for cancer-related inflammation [2, 8, 9]. Macrophages are a double-edged sword, with the potential to express pro and anti-tumor activity (the macrophage balance [10, 11]), the former prevailing in established neoplasia. Here we will focus on selected molecular pathways underlying TAM recruitment and polarization, emphasizing the dual potential of cancer-related inflammation [12] and the diversity of pathways and functions in different tumors.
Section snippets
Chemokines in TAM recruitment and carcinogenesis: doubt no more
TAM recruitment in tumors is mediated by cytokines belonging to different classes including colony stimulating factor-1 [13], vascular endothelial growth factor and chemokines [14]. Moreover, the C5a complement component that interacts with a G protein coupled receptor as chemokines do, has also been recently shown to play a role in leukocyte recruitment in cancer-related inflammation (CRI) [15]. Thus, members of different molecular families can contribute to the shaping of CRI.
Inflammatory
Orchestration of TAM function and polarization: extracellular signals
Plasticity is a hallmark of mononuclear phagocytes. In response to diverse signals, macrophages undergo polarized activation. Classically activated (M1) macrophages, following exposure to interferon γ (IFNγ), have tumoricidal activity and elicit tissue destructive reactions. In response to IL-4 or IL-13, macrophages undergo alternative (M2) activation [10, 27]. In general, M2 cells obtained in response to IL-4 are oriented to tissue repair and remodelling, immunoregulation, and tumor promotion [
Molecular determinants of TAM functions
As mentioned above, TAM generally have phenotype and functions similar to alternative or M2 macrophages [2, 22•]. For example, TAM express low levels of the major histocompatibility complex class II and reduced antimicrobial and tumoricidal activity, while increasing production of mediators that promote angiogenesis, such as vascular endothelial growth factor and cyclo-oxygenase-2 (COX-2)-derived prostaglandin E2, as well as the anti-inflammatory cytokine IL-10 [2]. Another hallmark feature of
Promotion of invasion and metastasis
Macrophages and some of their products (IL-1; TNF; IL-6) have long been known to increase metastasis [2] and recent work has provided new evidence [33••, 34, 55, 56, 57]. In particular, cells of hematopoietic origin and specifically myelomonocytic cells have been shown to home and condition the premetastatic niche. Here they form a secondary niche that favors secondary localization of cancer [36, 58, 59•].
Tipping the balance
Certain forms of inflammation are protective in a preventive or therapeutic setting [2, 60, 61]. An immune response has long been known to contribute to the outcome of chemotherapy. It has now been shown that dying tumor cells can be cross presented by dendritic cells and trigger a protective immune response via a TLR4-MyD88 pathway [62]. Inflammasome activation and IL-1β production underlie ultimate activation of protective immunity [63••]. Association of TLR4 and PrX7 polymorphisms with
Concluding remarks: balance, tolerance, and diversity
Recent results have highlighted a striking similarity in terms of transcriptional profile, functional properties, and underlying transcription factors between TAM and ‘tolerant’ macrophage [51]. Tolerant macrophages belong to the wide spectrum and universe of M2-like polarized phagocytes. The finding that PMN have unsuspected plasticity and are subject to a P1–P2 balance in the tumor microenvironment [28•] calls for a reappraisal of their role and significance in cancer-related inflammation.
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
• of special interest
•• of outstanding interest
References (72)
- et al.
Inflammation and cancer: back to Virchow?
Lancet
(2001) - et al.
The origin and function of tumor-associated macrophages
Immunol Today
(1992) - et al.
Tumor immunity: effector response to tumor and the influence of the microenvironment
Lancet
(2008) - et al.
Microenvironmental regulation of metastasis
Nat Rev Cancer
(2009) - Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R: The chemokine system in cancer biology and...
- et al.
Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors
Cancer Res
(2009) - et al.
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Blood
(2008) - et al.
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Blood
(2008) - et al.
Polarization of tumor-associated neutrophil (TAN) phenotype by TGF-beta: “N1” versus “N2” TAN—a new paradigm?
Cancer Cell
(2009) - et al.
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
Blood
(2009)
Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated
Cancer Res
Carcinoma produced factors activate myeloid cells via TLR2 to stimulate metastasis
Nature
Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes
Blood
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines
Blood
Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions
Blood
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages
J Exp Med
Macrophage polarization in tumour progression
Semin Cancer Biol
Sica A: p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance
Cancer Res
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
Cancer Res
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Nature
Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy
Int J Cancer
Cancer immunoediting: from immunosurveillance to tumor escape
Nat Immunol
Cancer-related inflammation
Nature
Inflammation and cancer
Nature
Cancer: inflaming metastasis
Nature
NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha
Nature
Nuclear factor-kappaB in cancer development and progression
Nature
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Nat Rev Immunol
Trophic macrophages in development and disease
Nat Rev Immunol
Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications
Trends Immunol
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
Trends Immunol
Is complement good or bad for cancer patients? A new perspective on an old dilemma
Trends Immunol
Regulation of the macrophage content of neoplasms by chemoattractants
Science
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors
J Clin Invest
Cited by (1207)
Unlocking the secrets: Volatile Organic Compounds (VOCs) and their devastating effects on lung cancer
2024, Pathology Research and PracticeParticipation of B cell in immunotherapy of cancer
2024, Pathology Research and PracticeTargeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
2024, Biochimica et Biophysica Acta - Reviews on Cancer